253.5p 0.5 0.2%
Last Trade - 12/04/21
| Market Cap | £545.1m |
| Enterprise Value | £502.4m |
| Revenue | £86.8m |
| Position in Universe | 582nd / 1817 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 68.6 | 83.2 | 96.9 | 102.6 | 102.4 | 86.8 | 109.3 | 122.7 | +4.8% | ||
| +9.9 | +13.3 | +24.1 | +12.4 | -13.8 | -51.8 | +101.8 | +21.8 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials. Its Branded Direct segment is engaged in selling, marketing and innovation of its branded products sold directly by its sales teams. Its Branded Distributed segment is engaged in distribution, marketing and innovation of its brands sold by distributors in markets not serviced by its sales team. Its OEM segment is engaged in selling, marketing and innovation of its products supplied to partners under their brands. Its Bulk Materials segment is engaged in selling, marketing and innovation of bulk materials to medical device partners and convertors. Its products include ActivHeal, LiquiBand and RESORBA.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | November 1, 1993 |
| Public Since | April 30, 2002 |
| No. of Shareholders: | n/a |
| No. of Employees: | 700 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | FTSE Aim All Share , FTSE Aim 100 , FTSE Intl-aim UK 50 , |
| Exchange | London Stock Exchange (AIM) |
| Shares in Issue | 215,473,287 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Premier Park 33 Road One, WINSFORD, CW7 3RT, United Kingdom |
| Web | https://www.admedsol.com/ |
| Phone | +44 1606 863500 |
| Contact | () |
| Auditors | Deloitte LLP |
As of 12/04/21, shares in Advanced Medical Solutions are trading at 253.5p, giving the company a market capitalisation of £545.1m. This share price information is delayed by 15 minutes.
Shares in Advanced Medical Solutions are currently trading at 253.5p and the price has moved by 4.76% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Advanced Medical Solutions price has moved by -15.36% over the past year.
Of the analysts with advisory recommendations for Advanced Medical Solutions, there are there are currently 2 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Advanced Medical Solutions is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Advanced Medical Solutions is scheduled to issue upcoming financial results on the following dates:
The Advanced Medical Solutions dividend yield is 0.67% based on the trailing twelve month period.
Last year, Advanced Medical Solutions paid a total dividend of 0.02, and it currently has a trailing dividend yield of 0.67%. Looking ahead, shares in Advanced Medical Solutions are due to go ex-dividend on 2021-05-27 and the next dividend pay date is 2021-06-18.
Advanced Medical Solutions are due to go ex-dividend on 2021-05-27 and the next dividend pay date is 2021-06-18. The historic dividend yield on Advanced Medical Solutions shares is currently 0.67%.
To buy shares in Advanced Medical Solutions you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Advanced Medical Solutions are currently trading at 253.5p, giving the company a market capitalisation of £545.1m.
Here are the trading details for Advanced Medical Solutions:
Based on an overall assessment of its quality, value and momentum, Advanced Medical Solutions is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Advanced Medical Solutions are currently priced at 253.5p. At that level they are trading at 7.05% discount to the analyst consensus target price of 272.73.
Analysts covering Advanced Medical Solutions currently have a consensus Earnings Per Share (EPS) forecast of 0.08847 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Advanced Medical Solutions. Over the past six months, the relative strength of its shares against the market has been -2.25%. At the current price of 253.5p, shares in Advanced Medical Solutions are trading at 11.51% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Advanced Medical Solutions PE ratio based on its reported earnings over the past 12 months is 57.71. The shares are currently trading at 253.5p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Advanced Medical Solutions's management team is headed by:
Here are the top five shareholders of Advanced Medical Solutions based on the size of their shareholding:
